Sole-Source Justification-TAPESTATION 4150_Redacted_ CO signed 11 Sep 2024.pdf

CDC

JUSTIFICATION FOR SOLE SOURCE PROCUREMENT (OPEN MARKET OR GSA)

UNDER $250,000

Sole source acquisitions may be used on a limited basis and only when the Contracting Officer’s Representative (COR)/Program Official has provided sufficient justification and the Contracting Officer has determined that the circumstances warrant such action. The content for a justification must contain detailed facts and rationale to justify the sole source acquisition. Soliciting from a single source must be done in accordance with FAR 13.106-1(b) or 8.405-6. At a minimum, the following information must be included:

Identification of Program Office, Contracting Activity, and Proposed Requirement, Justification and Program Office Certification:

A. Program Office:

Centers for Disease Control and Prevention

NCEZID/DVBD/Dengue Branch 1324 Cañada St.

San Juan, PR 00920

B. Contracting Activity:

Centers for Disease Control and Prevention Office of Acquisition Services 2920 Brandywine Road, Mail Stop K-69 Atlanta, GA 30341

C. Identification of Requirement:

1. Nature of Action to be Approved by Contracting Officer:

a. Brand Name Justification: Tapestation 4150

b. Procurement Request (PR) Number (if available):

2. Proposed Manufacturer and Estimated Procurement Amount (if available):

a. Proposed Manufacturer: Agilent Technologies Inter-Americas Inc

b. Estimated Procurement Amount:

3. Is the requirement on GSA Schedule? ☐ Yes ☒ No

If yes, provide schedule number: Click here to enter text.

D. Justification:

1. The justification for this non-competitive action is:

Rev. 5/14/19

☐ In accordance with FAR 13.106-1(b)(1), “only one source [is] reasonably available” which states that, “For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available (e.g., urgency, exclusive licensing agreements, brand-name or industrial mobilization). (ii) Where a single source is identified to provide a portion of a purchase because that portion of the purchase specifies a particular brand-name item, the documentation in paragraph (b)(1)(i) of this section only applies to the portion of the purchase requiring brand-name item. The documentation should state it is covering only the portion of the acquisition which is brand-name.”

☐ Urgency

☐ Exclusive licensing agreements/Proprietary data

☐ Brand name required

☐ Industrial mobilization

☐ Other (e.g., compatibility, space issues, continuity, compatibility, etc.)

☒ In accordance with FAR 8.405-6 “Limiting Sources” which states that, “the only circumstances that may justify the action are – (A) An urgent and compelling need exists, and following the procedures would result in unacceptable delays; (B) Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized; or (C) In the interest of economy and efficiency, the new work is a logical follow-up to an original Federal Supply Schedule order provided that the original order was placed in accordance with the applicable Federal Supply Schedule ordering procedures. The original BPA must not have been previously issued under sole-source or limited-sources procedures.”

☐ Urgency

☐ Only One Source

☐ Logical Follow Up

☒ Brand name required

2. Other facts supporting sole source procurement:

a. What can this product/service do that other products/services cannot do?

The 4150 TapeStation system is an economic, low-throughput automated electrophoresis platform for nucleic acid sample quality control. Building on the success of the proven ScreenTape technology, it allows a quick, easy, and reliable analysis of DNA and RNA samples for up to 16 samples per run. This affordable, entry-level system is the ideal solution for the quality control (QC) of RNA and DNA samples in next-generation sequencing (NGS), biobank, or vaccine development workflows.

b. What other products/services were considered and why did they not meet the need?

Most of the automated electrophoresis offered in the market are not compatible with our sample inventory accessories (placeholders, safety sample stands, etc.). It’s essential to continue uniformity in laboratory equipment for optimal laboratory efficiency in sample receiving and inventory management.